Search This Blog

Tuesday, September 11, 2018

Emergent BioSolutions (EBS) PT Raised to $68 at Cantor Fitzgerald


Cantor Fitzgerald analyst Brandon Folkes raised the price target on Emergent BioSolutions (NYSE: EBS) to $68.00 (from $62.00)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.